Literature DB >> 17671728

The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells.

Maren Möller1, Kerstin Herzer, Till Wenger, Ingrid Herr, Michael Wink.   

Abstract

Emetine, a natural alkaloid from Psychotria ipecacuanha, has been used in phytomedicine to induce vomiting, and to treat cough and severe amoebiasis. Certain data suggest the induction of apoptosis by emetine in leukemia cells. Therefore, we examined the suitability of emetine for the sensitisation of leukemia cells to apoptosis induced by cisplatin. In response to emetine, we found a strong reduction in viability, an induction of apoptosis and caspase activity comparable to the cytotoxic effect of cisplatin. Moreover, emetine had an additive effect and increased cisplatin-induced apoptosis. Mechanistically, we demonstrate by DNA array analysis that emetine alone or together with cisplatin down-regulates several anti-survival genes and up-regulates several pro-apoptotic signalling molecules along with other effects on signalling. These data show that emetine is a strong inducer of apoptosis in leukemia cells and could be a suitable cytotoxic drug alone or in combination with other chemotherapeutics to sensitise leukemia cells to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671728

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.

Authors:  Luke D Jasenosky; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

2.  Screening for Small Molecule Modulators of Trypanosoma brucei Hsp70 Chaperone Activity Based upon Alcyonarian Coral-Derived Natural Products.

Authors:  Sarah K Andreassend; Stephen J Bentley; Gregory L Blatch; Aileen Boshoff; Robert A Keyzers
Journal:  Mar Drugs       Date:  2020-01-27       Impact factor: 5.118

3.  Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery.

Authors:  Pulin Che; Long Cui; Olaf Kutsch; Liwang Cui; Qianjun Li
Journal:  Assay Drug Dev Technol       Date:  2011-11-03       Impact factor: 1.738

4.  Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines.

Authors:  Emmanuel S Akinboye; Zebalda D Bamji; Bernard Kwabi-Addo; David Ejeh; Robert L Copeland; Samuel R Denmeade; Oladapo Bakare
Journal:  Bioorg Med Chem       Date:  2015-07-04       Impact factor: 3.641

Review 5.  Modes of Action of Herbal Medicines and Plant Secondary Metabolites.

Authors:  Michael Wink
Journal:  Medicines (Basel)       Date:  2015-09-08

6.  Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.

Authors:  Sherif T S Hassan
Journal:  Viruses       Date:  2020-04-23       Impact factor: 5.048

7.  Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.

Authors:  Eunjee Lee; Ana Collazo-Lorduy; Mireia Castillo-Martin; Yixuan Gong; Li Wang; William K Oh; Matthew D Galsky; Carlos Cordon-Cardo; Jun Zhu
Journal:  Oncogene       Date:  2018-07-03       Impact factor: 9.867

8.  Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells.

Authors:  Ti-Hui Wu; Shan-Yueh Chang; Yu-Lueng Shih; Tsai-Wang Huang; Hung Chang; Ya-Wen Lin
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

9.  Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects.

Authors:  Rima Hajjo; Dima A Sabbah; Alexander Tropsha
Journal:  Pathogens       Date:  2022-06-29

10.  The β-carboline alkaloid harmine inhibits telomerase activity of MCF-7 cells by down-regulating hTERT mRNA expression accompanied by an accelerated senescent phenotype.

Authors:  Lei Zhao; Michael Wink
Journal:  PeerJ       Date:  2013-10-01       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.